Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
38,437,133
-
Shares change
-
+3,422,453
-
Total reported value, excl. options
-
$121,095,668
-
Value change
-
-$70,697,347
-
Put/Call ratio
-
0%
-
Number of buys
-
39
-
Number of sells
-
52
-
Price
-
$3.15
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2018
As of 31 Dec 2018 Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) had 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,437,133 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, CITADEL ADVISORS LLC, WS MANAGEMENT LLLP, and EVENTIDE ASSET MANAGEMENT, LLC.
This table shows 120 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.